Oncology Data Advisor

Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ

Informações:

Synopsis

In this interview, Dr. Jason Mouabbi speaks with Oncology Data Advisor about his research regarding the absence of lobular carcinoma in situ as a poor prognostic marker in invasive lobular carcinoma, which will be presented as a poster at the 2022 San Antonio Breast Cancer Symposium (SABCS).